Cortisol Metabolism in Human Obesity: Impaired Cortisone→Cortisol Conversion in Subjects with Central Adiposity1
The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
For a given body mass index (BMI), mortality is higher in patients with central compared to generalized obesity. Glucocorticoids play an important role in determining body fat distribution, but circulating cortisol concentrations are reported to be normal in obese patients. Our recent studies show enhanced conversion of inactive cortisone (E) to active cortisol (F) through the expression of 11beta-hydroxysteroid dehydrogenase type 1 (11betaHSD1) in cultured omental adipose stromal cells; the autocrine production of F may be a crucial factor in the pathogenesis of central obesity. We have now analyzed F metabolism in subjects with BMIs between 20-25 kg/m2 (group A), 25-30 kg/m2 (group B), and more than 30 kg/m2 (group C; n 12 in each group; six males and six premenopausal females; aged 23-44 yr). Glucose/insulin were measured using a 75-g oral glucose tolerance test, and each subject had total body and regional fat (scapular, waist, hip, and thigh) quantified using dual energy x-ray absorptiometry. Urinary total F metabolites (measured by gas chromatography/mass spectrometry) were increased in subjects with obesity [group A, 11,176 +/- 1,530 microg/24 h (mean +/- SE); group C, 13,661 +/- 1,444], although not significantly so (P = 0.08). There was a significant reduction in the urinary tetrahydrocortisol (THF) +/- 5alpha-THF/tetrahydrocortisone (THE) and the cortol/cortolone ratio in obesity (group A vs. C, 1.06 +/- 0.08 vs. 0.84 +/- 0.04 and 0.41 +/- 0.03 vs. 0.34 +/- 0.03, respectively; both P < 0.05). Urinary free F (UFF) excretion was similar in all three groups, as was the UFF/urinary free E (UFE) ratio. The 0900 h circulating F, E, and ACTH pre- and postovernight 1-mg dexamethasone suppression values were similar in all three groups, but a reduction in the generation of serum F from dexamethasone-suppressed values after oral cortisone acetate (25 mg) was evident in both obese groups [e.g. 546 +/- 37 nmol/L in group A vs. 412 +/- 40 in group B (P < 0.05) and 388 +/- 38 in group C (P < 0.01) 180 min post-E]. Insulin resistance was present in groups B and C, but regression analysis revealed no relationship between F metabolites or the THF +/- 5alpha-THF/THE ratio and insulin action (homeostasis model assessment analysis and insulin values in the oral glucose tolerance test). There was, however, a highly significant relationship between the THF +/- 5alpha-THF/THE ratio and BMI (t = -3.44; P < 0.01) and total body fat (t = -2.27; P < 0.05). Stepwise regression analyses indicated an inverse relationship between THF+/-5alpha-THF/THE and scapular and waist fat (t = -2.25; P = 0.03) and a direct relationship with hip and thigh fat (t = 2.42; P = 0.02) in both sexes. The fall in the THF + 5alpha-THF/THE ratio but unchanged UFF/UFE ratio together with impaired F concentrations after oral E indicates inhibition of 11betaHSD1 in subjects with obesity. This results in an increased MCR for F, explaining the increased F secretion rate in obesity in the face of normal circulating F concentrations. 11BetaHSD1 activity is highly related to body fat distribution, with android or central obesity, but not gynoid obesity, associated with reduced activity in both sexes. This reduction in 11betaHSD1 activity raises new questions as to the primary role of 11betaHSD1 in the pathogenesis of insulin resistance and central obesity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As surrogate measures of adverse metabolic risk (27), AVF and omental fat-cell size have been associated in some but not all studies with increased activity or expression of 11β-hydroxysteroid dehydrogenase type 1, which promotes conversion of inactive cortisone to active cortisol (28–31).”
From Glucose ingestion selectively amplifies ACTH and cortisol secretory-burst mass and enhances their joint synchrony in healthy men. (2011) · cites this paper as [31]
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Kotelevtsev, Y., Holmes, M. C., Burchell, A., Houston, P. M., Schmoll, D., Jamieson, P., Best, R., Brown, R., Edwards, C. R. W., Seckl, J. R., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14924 · Cited by 858
Does central obesity reflect “Cushing's disease of the omentum”?
Bujalska, I. J., Kumar, S., & Stewart, P. M. (1997) · The Lancet · doi:10.1016/s0140-6736(96)11222-8 · Cited by 753 · cited 2×
“increased expression of 11bHSD1 in human adipose stromal cells from omental compared with sc depots (21).”
Self-citationSex- and menopause-associated changes in body-fat distribution
Ley, C., Lees, B., & Stevenson, J. (1992) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/55.5.950 · Cited by 733
Cloning and tissue distribution of the human 1 lβ-hydroxysteroid dehydrogenase type 2 enzyme
Albiston, A. L., Obeyesekere, V. R., Smith, R. E., & Krozowski, Z. S. (1994) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(94)90176-7 · Cited by 712
(1996) · PubMed · Cited by 643
11β-Hydroxysteroid Dehydrogenase and the Syndrome of Apparent Mineralocorticoid Excess*
White, P. C., Mune, T., & Agarwal, A. K. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0288 · Cited by 517
Cortisol secretion in relation to body fat distribution in obese premenopausal women
Mårin, P., Darin, N., Amemiya, T., Andersson, B., Jern, S., & Björntorp, P. (1992) · Metabolism · doi:10.1016/0026-0495(92)90171-6 · Cited by 458
Tannin, G. M., Agarwal, A. K., Monder, C., New, M. I., & White, P. C. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55351-5 · Cited by 436
Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle.
Stewart, P. M., Corrie, J. E., Shackleton, C. H., & Edwards, C. R. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113592 · Cited by 430
Self-citation
Cited by
Items 201–300 of 415
Reduced 11β-hydroxysteroid dehydrogenase type 1 activity in obese boys
Wiegand, S., Richardt, A., Remer, T., Wudy, S. A., Tomlinson, J. W., Hughes, B., Grüters, A., Stewart, P. M., Strasburger, C. J., & Quinkler, M. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0193 · Cited by 37
Self-citationThe Role of 11 β-Hydroxysteroid Dehydrogenase in Central Obesity and Osteoporosis
Tomlinson, J., Bujalska, I., Stewart, P., & Cooper, M. (2000) · Endocrine Research · doi:10.3109/07435800009048591 · Cited by 37
Self-citationBrief review: Glucocorticoid excretion in obesity
Müssig, K., Remer, T., & Maser-Gluth, C. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.01.008 · Cited by 36
Barat, P., Gayard-Cros, M., Andrew, R., Corcuff, J., Jouret, B., Barthe, N., Perez, P., Germain, C., Tauber, M., Walker, B. R., et al. (2007) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2007.01.029 · Cited by 36
Effect of Nutrient Ingestion on Total-Body and Splanchnic Cortisol Production in Humans
Basu, R., Singh, R., Basu, A., Johnson, C. M., & Rizza, R. A. (2006) · Diabetes · doi:10.2337/diabetes.55.03.06.db05-1335 · Cited by 37
11β‐Hydroxysteroid Dehydrogenase Type 1 in Obesity
Walker, B. R. (2004) · Obesity Research · doi:10.1038/oby.2004.1 · Cited by 36
Increased systemic and adipose 11β-HSD1 activity in idiopathic intracranial hypertension
Westgate, C. S. J., Markey, K. A., Mitchell, J., Yiangou, A., Singhal, R., Stewart, P. M., Tomlinson, J., Lavery, G. G., Mollan, S. P., & Sinclair, A. J. (2022) · European Journal of Endocrinology · doi:10.1530/eje-22-0108 · Cited by 36
Self-citationSteroid metabolism in Metabolic Syndrome X
Walker, B. R. (2001) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1053/beem.2000.0123 · Cited by 38
Association of estrogen with glucocorticoid levels in visceral fat in postmenopausal women
Yamatani, H., Takahashi, K., Yoshida, T., Takata, K., & Kurachi, H. (2013) · Menopause · doi:10.1097/gme.0b013e318271a640 · Cited by 34
Rosiglitazone decreases 11β‐hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue
Mai, K., Andres, J., Bobbert, T., Maser‐Gluth, C., Möhlig, M., Bähr, V., Pfeiffer, A. F. H., Spranger, J., & Diederich, S. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02903.x · Cited by 36
Inhibition of 11β-Hydroxysteroid Dehydrogenase Type 1 in Obesity
Wake, D. J., & Walker, B. R. (2006) · Endocrine · doi:10.1385/endo:29:1:101 · Cited by 37
Gambineri, A., Forlani, G., Munarini, A., Tomassoni, F., Cognigni, G. E., Ciampaglia, W., Pagotto, U., Walker, B. R., & Pasquali, R. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03346454 · Cited by 33
Adipocyte metabolism and the metabolic syndrome
Stears, A. J., & Byrne, C. D. (2001) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2001.00151.x · Cited by 42
Torrecilla, E., Fernández‐Vázquez, G., Vicent, D., Sánchez‐Franco, F., Barabash, A., Cabrerizo, L., Sánchez-Pernaute, A., Torres, A. J., & Rubio, M. Á. (2011) · Obesity Surgery · doi:10.1007/s11695-011-0524-9 · Cited by 35
Müssig, K., Remer, T., Haupt, A., Gallwitz, B., Fritsche, A., Häring, H., & Maser‐Gluth, C. (2008) · Obesity · doi:10.1038/oby.2008.218 · Cited by 38
Klöting, N., Blüher, M., & Klöting, I. (2005) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.582 · Cited by 32
Svendsen, P. F., Madsbad, S., Nilas, L., Paulsen, S. K., & Pedersen, S. B. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.165 · Cited by 33
Urinary glucocorticoid metabolites: biomarkers to classify adrenal incidentalomas?
Brossaud, J., Ducint, D., & Corcuff, J. (2016) · Clinical Endocrinology · doi:10.1111/cen.12717 · Cited by 30
Edgerton, D. S., Basu, R., Ramnanan, C. J., Farmer, T. D., Neal, D. W., Scott, M. F., Jacobson, P. B., Rizza, R. A., & Cherrington, A. D. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00740.2009 · Cited by 30
11β Hydroxysteroid dehydrogenase – 1 activity in type 2 diabetes mellitus: a comparative study
Shukla, R. K. G., Basu, A. K., Mandal, B., Mukhopadhyay, P., Maity, A., Chakraborty, S., & Devrabhai, P. K. (2019) · BMC Endocrine Disorders · doi:10.1186/s12902-019-0344-9 · Cited by 31
Liu, Y. U., Park, F., Pietrusz, J. L., Jia, G., Singh, R. J., Netzel, B. C., & Liang, M. (2007) · Physiological Genomics · doi:10.1152/physiolgenomics.00067.2007 · Cited by 32
Dammann, C., Stapelfeld, C., & Maser, E. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.02.018 · Cited by 30
New evaluations of redox regulating system in adipose tissue of obesity
Park, J., Chung, J.-J., & Kim, J. B. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.01.037 · Cited by 31
Plenis, A., Konieczna, L., Olędzka, I., Kowalski, P., & Bączek, T. (2011) · Molecular BioSystems · doi:10.1039/c0mb00313a · Cited by 31
Interactions between cortisol and lipids in human milk
Linderborg, K. M., Kortesniemi, M. K., Aatsinki, A., Karlsson, L., Karlsson, H., Yang, B., & Uusitupa, H. (2020) · International Breastfeeding Journal · doi:10.1186/s13006-020-00307-7 · Cited by 29
Siggelkow, H., Etmanski, M., Bozkurt, S., Groβ, P., Koepp, R., Brockmöller, J., & Tzvetkov, M. V. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1418 · Cited by 29
Tenk, J., Mátrai, P., Hegyi, P., Rostás, I., Garami, A., Szabó, I., Solymár, M., Pétervári, E., Czimmer, J., Márta, K., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166842 · Cited by 36
Maternal influences on the glucocorticoid concentrations of human milk: The STEPS study
Pundir, S., Mäkelä, J., Nuora, A., Junttila, N., Wall, C. R., Linderborg, K. M., Cameron‐Smith, D., & Lagström, H. (2018) · Clinical Nutrition · doi:10.1016/j.clnu.2018.06.980 · Cited by 31
Wang, Y., Nakagawa, Y., Liu, L., Wang, W., Ren, X., Anghel, A., Lutfy, K., Friedman, T. C., & Liu, Y. (2010) · Diabetologia · doi:10.1007/s00125-010-1956-9 · Cited by 29
Espíndola-Antunes, D., & Kater, C. E. (2007) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302007000800027 · Cited by 33
Circadian rhythm of urinary steroid metabolites
Jerjes, W. K., Cleare, A. J., Peters, T. J., & Taylor, N. (2006) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/000456306777695564 · Cited by 28
Barrea, L., Verde, L., Camajani, E., Šojat, A. S., Marina, L., Savastano, S., Colao, A., Caprio, M., & Muscogiuri, G. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02068-6 · Cited by 30
Czegle, I., Csala, M., Mandl, J., Benedetti, A., Karádi, I., & Bánhegyi, G. (2012) · World Journal of Hepatology · doi:10.4254/wjh.v4.i4.129 · Cited by 30
Loerz, C., & Maser, E. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2017.07.030 · Cited by 30
Morita, H., Isomura, Y., Mune, T., Daido, H., Takami, R., Yamakita, N., Ishizuka, T., Takeda, N., Yasuda, K., & Gómez-Sánchez, C. E. (2003) · Metabolism · doi:10.1016/j.metabol.2003.06.005 · Cited by 30
Crowley, R. K., Hughes, B., Gray, J., McCarthy, T., Hughes, S., Shackleton, C. H. L., Crabtree, N., Nightingale, P., Stewart, P. M., & Tomlinson, J. W. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0256 · Cited by 26
Self-citationNikolaou, N., Hodson, L., & Tomlinson, J. (2021) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2021.105808 · Cited by 30
Smit, P., Dekker, M. J. H. J., de Jong, F. J., van den Beld, A. W., Koper, J. W., Pols, H. A. P., Brinkmann, A. O., de Jong, F. H., Breteler, M. M. B., & Lamberts, S. W. J. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1349 · Cited by 26
The influence of biological and environmental factors on metallothionein concentration in the blood
Kowalska, K., Bizoń, A., Zalewska, M., & Milnerowicz, H. (2014) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2014.05.001 · Cited by 26
What is the best approach to tailoring hydrocortisone dose to meet patient needs in 2012?
Debono, M., & Ross, R. J. M. (2013) · Clinical Endocrinology · doi:10.1111/cen.12117 · Cited by 30
Burén, J., Bergström, S.-A., Loh, E., Söderström, I., Olsson, T., & Mattsson, C. (2007) · Endocrinology · doi:10.1210/en.2006-0897 · Cited by 26
Evidence for disruption of normal circadian cortisol rhythm in women with obesity
Al-Safi, Z. A., Polotsky, A. J., Chosich, J., Roth, L. W., Allshouse, A. A., Bradford, A. P., & Santoro, N. F. (2017) · Gynecological Endocrinology · doi:10.1080/09513590.2017.1393511 · Cited by 28
The human obesity epidemic, the mismatch paradigm, and our modern “captive” environment
Power, M. L. (2012) · American Journal of Human Biology · doi:10.1002/ajhb.22236 · Cited by 30
Rogers, S. L., Hughes, B. A., Jones, C. A., Freedman, L., Smart, K., Taylor, N., Stewart, P. M., Shackleton, C. H. L., Krone, N. P., Blissett, J., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3254 · Cited by 25
Self-citationLiu, J., Wang, L., Zhang, A., Di, W., Zhang, X., Wu, L., Yu, J., Zha, J., Lv, S., Cheng, P., et al. (2011) · Endocrine Journal · doi:10.1507/endocrj.k10e-318 · Cited by 26
Nguyen, S. T., Minh, T. B., Dinh, H. T., Le, T. D., Nguyen, N. P. T., Tran, T. T. H., Vu, T. H., Công, T. L., Nguyen, L. H. T., Pham, P. T., et al. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s400995 · Cited by 25
Stewart, P. M. (2005) · Clinical Medicine · doi:10.7861/clinmedicine.5-2-142 · Cited by 35
Self-citationSaba, A., Raffaelli, A., Cupisti, A., Petri, A., Marcocci, C., & Salvadori, P. A. (2008) · Journal of Mass Spectrometry · doi:10.1002/jms.1530 · Cited by 25
Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1 in Antidiabetic Therapy
Wang, M. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-17214-4_6 · Cited by 29
Nikolaou, N., Gathercole, L., Kirkwood, L., Dunford, J. E., Hughes, B. A., Gilligan, L. C., Oppermann, U. C. T., Penning, T. M., Arlt, W., Hodson, L., et al. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.02.002 · Cited by 25
Obesity; epiphenomenon or cause of metabolic syndrome?
Lois, K. B., Young, J., & Kumar, S. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01773.x · Cited by 33
Self-citationRoelfsema, F., Kok, P., Pereira, A. M., & Pijl, H. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2701 · Cited by 23
Selenium deficiency impairs corticosterone and leptin responses to adrenocorticotropin in the rat
Chanoine, J., Wong, A. C. K., & Lavoie, J. (2004) · BioFactors · doi:10.1002/biof.5520200205 · Cited by 24
Sex Differences in Metabolic and Adipose Tissue Responses to Juvenile-Onset Obesity in Sheep
Bloor, I. D., Sebert, S. P., Saroha, V., Gardner, D. S., Keisler, D. H., Budge, H., Symonds, M. E., & Mahajan, R. P. (2013) · Endocrinology · doi:10.1210/en.2013-1207 · Cited by 23
LACK OF MUTATIONS OF TYPE 1 11β-HYDROXYSTEROID DEHYDROGENASE GENE IN PATIENTS WITH ABDOMINAL OBESITY
Caramelli, E., Strippoli, P., Giacomi, T. D., Tietz, C., Carinci, P., & Pasquali, R. (2001) · Endocrine Research · doi:10.1081/erc-100107169 · Cited by 26
Putignano, P., Giraldi, F. P., & Cavagnini, F. (2004) · Journal of Endocrinological Investigation · doi:10.1007/bf03347544 · Cited by 23
Production Rates of Cortisol in Obesity
Vierhapper, H., Nowotny, P., & Waldhäusl, W. (2004) · Obesity Research · doi:10.1038/oby.2004.178 · Cited by 24
Increased Response of Plasma Allopregnanolone to Corticotropin-Releasing Hormone in Obese Patients
Menozzi, R., Florio, P., Bondi, M., Luisi, S. V., Cobellis, L., Genazzani, A. R., Rio, G. D., & Petraglia, F. (2002) · Neuroendocrinology · doi:10.1159/000048228 · Cited by 22
Dexras1 plays a pivotal role in maintaining the equilibrium between adipogenesis and osteogenesis
Seok, J. W., Kim, D., Yoon, B. K., Lee, Y., Kim, H. J., Hwang, N., Fang, S., Kim, H. J., & Kim, J. W. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154250 · Cited by 23
Sukhija, R., Kakar, P., Mehta, V., & Mehta, J. L. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.03.028 · Cited by 25
Güldiken, S., Tunçbilek, N., Ökten, Ö., Arıkan, E., & Tuğrul, A. (2006) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2005.00803.x · Cited by 24
Walker, B. R., Rodin, A., Taylor, N., & Clayton, R. N. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.00893.x · Cited by 21
Ayari, H., Legedz, L., Cerutti, C., Lantelme, P., Feugier, P., Gustin, M., Lohez, O. D., Nehme, A., Li, J. Y., GHARBI-CHIHI, J., et al. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1193-7 · Cited by 21
Bini, J., Bhatt, S., Hillmer, A. T., Gallezot, J., Nabulsi, N., Pracitto, R., Labaree, D. C., Kapinos, M., Ropchan, J. R., Matuskey, D., et al. (2020) · Molecular Imaging and Biology · doi:10.1007/s11307-020-01490-z · Cited by 20
Pituitary-adrenal axis and peripheral cortisol metabolism in obese patients
Ceccato, F., Lizzul, L., Barbot, M., & Scaroni, C. M. (2020) · Endocrine · doi:10.1007/s12020-020-02392-4 · Cited by 21
Prevalence of hypogonadism in patients with type 2 diabetes mellitus among the Indian population
Anupam, B., Shivaprasad, C., Vijaya, S., Atluri, S., Aiswarya, Y., & Nikhil, K. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.07.006 · Cited by 21
Dumesic, D. A., Turcu, A. F., Liu, H., Grogan, T., Abbott, D. H., Lu, G., Dharanipragada, D., & Chazenbalk, G. D. (2023) · Journal of the Endocrine Society · doi:10.1210/jendso/bvad079 · Cited by 20
Cortisol and the polycystic ovary syndrome
Pasquali, R., & Gambineri, A. (2012) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.12.42 · Cited by 23
Główka, F. K., Kosicka, K., & Karaźniewicz‐Łada, M. (2009) · Journal of Chromatography B · doi:10.1016/j.jchromb.2009.11.016 · Cited by 20
Hepşen, S., Sencar, M. E., Sakız, D., Akhanlı, P., Uçan, B., Ünsal, İ. Ö., Özbek, M., & Çakal, E. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108081 · Cited by 21
Obesity and Hormonal Abnormalities
Pasquali, R., & Vicennati, V. (2001) · Wiley eBooks · doi:10.1002/0470846739.ch17 · Cited by 24
α2‐adrenoceptor regulation of the hypothalamic‐pituitary‐adrenocortical axis in obesity
Pasquali, R., Vicennati, V., Calzoni, F., Gnudi, U., Gambineri, A., Ceroni, L., Cortelli, P., Menozzi, R., Sinisi, R., & Rio, G. D. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.00871.x · Cited by 23
A gene variant of 11β-hydroxysteroid dehydrogenase type 1 is associated with obesity in children
Olza, J., Gil‐Campos, M., Leis, R., Rupérez, A. I., Tojo, R., Cañete, R., Gil, Á., & Aguilera, C. M. (2012) · International Journal of Obesity · doi:10.1038/ijo.2012.4 · Cited by 22
Banasik, J. L., Walker, M. K., Randall, J. M., Netjes, R. B., & Foutz, M. S. (2012) · Journal of the American Association of Nurse Practitioners · doi:10.1111/j.1745-7599.2012.00808.x · Cited by 21
Huang, C., Wan, B., Gao, B., Hexige, S., & Yu, L. (2009) · Acta Biochimica Polonica · doi:10.18388/abp.2009_2460 · Cited by 23
Sherlock, M., Behan, L., Hannon, M. J., Alonso, A. A., Thompson, C. J., Murray, R. D., Crabtree, N. J., Hughes, B. A., Arlt, W., Agha, A., et al. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0490 · Cited by 19
Self-citationGlucose Homeostasis and Cardiovascular Alterations in Diabetes
Xiang, L., Mittwede, P. N., & Clemmer, J. S. (2015) · Comprehensive physiology · doi:10.1002/cphy.c150001 · Cited by 20
Paulsen, S. K., Nielsen, M. P., Richelsen, B., Bruun, J. M., Flyvbjerg, A., & Pedersen, S. B. (2008) · Obesity · doi:10.1038/oby.2008.2 · Cited by 23
Effects of Gonadectomy on Glucocorticoid Metabolism in Obese Zucker Rats
Barat, P., Livingstone, D. E. W., Elferink, C. M. C., McDonnell, C., Walker, B. R., & Andrew, R. (2007) · Endocrinology · doi:10.1210/en.2007-0597 · Cited by 24
Iranmanesh, A., Lawson, D., Dunn, B., & Veldhuis, J. D. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0682 · Cited by 17
Erythropoietin negatively regulates pituitary ACTH secretion
Dey, S., Scullen, T. A., & Noguchi, C. T. (2015) · Brain Research · doi:10.1016/j.brainres.2015.02.052 · Cited by 17
Association of serum cortisol levels with parameters of metabolic syndrome in men and women
Esteghamati, A., Morteza, A., Khalilzadeh, O., Noshad, S., Novin, L., & Nakhjavani, M. (2011) · Clinical and investigative medicine · doi:10.25011/cim.v34i3.15185 · Cited by 17
Urinary cortisol to cortisone metabolites in hypertensive obese children
Csábí, G., Juricskay, S., & Molnár, D. (2000) · Journal of Endocrinological Investigation · doi:10.1007/bf03343752 · Cited by 18
2 Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1
Su, X., Vicker, N., & Potter, B. V. L. (2008) · Progress in medicinal chemistry · doi:10.1016/s0079-6468(07)00002-1 · Cited by 18
Adrenal responsiveness to high, low and very low ACTH 1–24 doses in obesity
Maccario, M., Grottoli, S., DiVito, L., Rossetto, R., Tassone, F., Ganzaroli, C., Oleandri, S. E., Arvat, E., & Ghigo, E. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.01120.x · Cited by 17
Dodd, S., Skvarc, D., Dean, O. M., Anderson, A., Kotowicz, M. A., & Berk, M. (2022) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyac014 · Cited by 16
Metabolic syndrome in patients with hematological diseases
Annaloro, C., Airaghi, L., Saporiti, G., Onida, F., Cortelezzi, A., & Deliliers, G. L. (2012) · Expert Review of Hematology · doi:10.1586/ehm.12.35 · Cited by 19
Dube, S., Norby, B., Pattan, V., Lingineni, R. K., Singh, R. J., Carter, R. E., Basu, A., & Basu, R. (2014) · Diabetologia · doi:10.1007/s00125-014-3240-x · Cited by 18
Chan, A. O.-K., Taylor, N., Tiu, S. C., & Shek, C. C. (2008) · Steroids · doi:10.1016/j.steroids.2008.03.004 · Cited by 17
Glucocorticoid Sensitivity: The Hypothalamic‐Pituitary‐Adrenal‐Tissue Axis
Syed, A. A., & Weaver, J. U. (2005) · Obesity Research · doi:10.1038/oby.2005.132 · Cited by 18
Kosicka, K., Cymerys, M., Majchrzak‐Celińska, A., Chuchracki, M., & Główka, F. K. (2013) · Journal of Human Hypertension · doi:10.1038/jhh.2012.67 · Cited by 16
Ward, A. M. V., Syddall, H. E., Wood, P. J., Dennison, E. M., & Phillips, D. I. W. (2004) · Metabolism · doi:10.1016/j.metabol.2004.01.008 · Cited by 17
Canivell, S., Mohaupt, M. G., Ackermann, D., Pruijm, M. T., Guessous, I., Ehret, G., Escher, G., Péchère-Bertschi, A., Vogt, B., Devuyst, O., et al. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0807-7 · Cited by 17
Is ?Cushing?s disease of the omentum? an affliction of mouse and men?
Walker, B. R. (2004) · Diabetologia · doi:10.1007/s00125-004-1390-y · Cited by 16
“Cushing’s disease of the omentum” — Fat or fiction?
Tomlinson, J., & Stewart, P. M. (2004) · Journal of Endocrinological Investigation · doi:10.1007/bf03346264 · Cited by 16
Self-citationMino‐León, D., Amato, D., Cuevas, M. L., Fonseca, M. E., Búrbano, G., Wacher, N. H., & Lifshitz, A. (2002) · Archives of Medical Research · doi:10.1016/s0188-4409(02)00400-9 · Cited by 16
Roelfsema, F., Kok, P., Frölich, M., Pereira, A. M., & Pijl, H. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0350 · Cited by 14
Homology modeling and structural analysis of 11β-hydroxysteroid dehydrogenase type 2
Yamaguchi, H., Akitaya, T., Yu, T., Kidachi, Y., Kamiie, K., Noshita, T., Umetsu, H., & Ryoyama, K. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.01.054 · Cited by 19
Li, C., Zhang, Z., Liu, X., Shen, K., Gu, P., & Kang, X. (2017) · Journal of Chromatography B · doi:10.1016/j.jchromb.2017.07.012 · Cited by 15
How will we know if 11β‐hydroxysteroid dehydrogenases are important in common diseases*
Walker, B. R. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.00969.x · Cited by 15
Metadata
- Authors
- Stewart, P. M., Boulton, A., Kumar, S., Clark, P. M. S., & Shackleton, C. H. L.
- Affiliations
- Queen Elizabeth Hospital Birmingham (GB)
- National Health Service (GB)
- Corresponding author
- Stewart, Paul M.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1999-03
- Volume
- 84
- Issue
- 3
- Pages
- 1022-1027
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2165935278
- Cited by
- 398
- References
- 43
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 4 · 2022: 5 · 2021: 2 · 2020: 11 · 2019: 4 · 2018: 3 · 2017: 10 · 2016: 10 · 2015: 19 · 2014: 18 · 2013: 10 · 2012: 19
- FWCI
- 14.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Keywords
- cortisol metabolism, abdominal obesity, cortisone to cortisol conversion, 11β-hydroxysteroid dehydrogenase type 1, urinary free cortisol, dexamethasone suppression, ACTH, body fat distribution, glucocorticoid metabolism, obesity pathogenesis, insulin resistance
- MeSH terms
- Adipose Tissue, Adult, Body Constitution, Cortisone, Female, Humans, Hydrocortisone, Male, Obesity, Tetrahydrocortisol, Tetrahydrocortisone, Body Mass Index
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.